Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
In Vitro Maturation in Oocyte Donors (MIVODON-II)
NCT06103383Recruiting
- Sponsor
- IVI
- Start
- Feb 2023
- Primary completion
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of human menopausal gonadotrophin in female infertility, sponsored by IVI. Primary endpoints: Oocyte in-vitro maturation at 1 year and Oocyte activation at 1 year. Started Feb 2023; status: recruiting.
02
Drugs
human menopausal gonadotrophin
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT06103383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06103383.